Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 421 AL 435

The role and therapeutic potential of DNA glycosylases in Alzheimer's disease

Zhao X, Li Y, Meng Z, Xu X, Chen L, Yu Q, Wang R, Ren Y, Chen F, Ai Q, Deng Y, Yu H, Wei J, Liang G.

Ageing Res Rev. 2026 Jun;118:103129. doi: 10.1016/j.arr.2026.103129. Epub 2026 Apr 10.

Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1(Glu280Ala) mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial

Tariot PN, Lopera FS, Ríos-Romenets S, Sink KM, Giraldo-Chica M, Acosta-Baena N, Villegas G, Espinosa A, Castaño ML, Muñoz C, Ospina P, Bocanegra Y, Tirado V, Henao E, Cardona E, Luna E, Lopez H, Sánchez G, Collazos MM, Alvarez S, Aguillón D, Hu N, Clayton D, Bittner T, Schneider A, Dolton M, Poon V, Nguyen J, Thomas RG, Schneider LS, Chen K, Su Y, Alexander RC, Quiroz YT, Cai Y, Xu YR, Ostaszewski B, Selkoe DJ, Ashton NJ, Denkinger MN, Jakimovich LJ, Doody RS, Langbaum JB, Reiman EM.

Lancet Neurol. 2026 Feb;25(2):147-159. doi: 10.1016/S1474-4422(25)00426-0.

Elucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications

Soni U, Pujari R.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Apr 2;146:111660. doi: 10.1016/j.pnpbp.2026.111660. Epub 2026 Mar 6.

TREM2 as a possible link between Alzheimer's disease and diabetes mellitus

Chen W, Huang N, Huang W, Wang M, Luo Y, Huang J.

Exp Neurol. 2026 Jul;401:115739. doi: 10.1016/j.expneurol.2026.115739. Epub 2026 Mar 19.

Natural Chiral Scaffolds in Alzheimer's Disease: Therapeutic Potential, Mechanism, and Clinical Aspects

Singh A, Sahu SK, Sah AK.

Biomed Res Int. 2026;2026(1):e5968529. doi: 10.1155/bmri/5968529.

Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges

Qudoos MA, Elliott DP.

Sr Care Pharm. 2026 Apr 1;41(3):98-108. doi: 10.4140/TCP.n.2026.98.

Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease

Li J, Guo L, Cai W, Mei J, Liu J, Liu Y.

Drug Deliv. 2026 Dec 31;33(1):2645830. doi: 10.1080/10717544.2026.2645830. Epub 2026 Mar 20.

PANoptosis in Alzheimer's disease: The expanding landscape of programmed cell death mechanisms and therapeutic interventions

Paidlewar M, Kumari S, Dhapola R, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.

Free Radic Biol Med. 2026 Jul;250:80-98. doi: 10.1016/j.freeradbiomed.2026.03.053. Epub 2026 Mar 20.

Targeting Lipid Metabolism in Alzheimer's Disease: Emerging Insights and Future Directions

Balakrishnan J, Kannan S, Shanmugam K, Sugasini D.

J Integr Neurosci. 2026 Apr 21;25(4):48436. doi: 10.31083/JIN48436.

Protein Modifications and Quality Control System: Target for Alzheimer's Disease Therapy

Sheikh AM, Yano S, Tabassum S, Bhuiya J, Nagai A.

Int J Mol Sci. 2026 May 11;27(10):4266. doi: 10.3390/ijms27104266.

Lecanemab and Donanemab Combination Therapy for Alzheimer's Disease-The Cocktail May Work Even Better Together

Dinnerstein E.

Alzheimer Dis Assoc Disord. 2026 Jan-Mar 01;40(1):65-66. doi: 10.1097/WAD.0000000000000711. Epub 2026 Feb 24.

Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review

Jiang X, Lv G, Xiong X, Yuan J, Kevin Lu Z.

J Alzheimers Dis. 2026 May;111(1):102-114. doi: 10.1177/13872877261430376. Epub 2026 Mar 16.

Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implications

Chen P, Wang R, Zhou T, Sun Y, Kirchhoff F, Miao Z, Zhuang C.

Eur J Med Chem. 2026 Jun 5;310:118785. doi: 10.1016/j.ejmech.2026.118785. Epub 2026 Mar 18.

Efficacy, safety, and ARIA risk of anti-β-amyloid antibodies in early Alzheimer's disease: a systematic review, meta-analysis, and meta-regression

da Silva AMP, de Deus O, Januário Campos Cardoso L, Virgilio Ribeiro F, Froelich Meldola P, Rodrigues Menezes I, Lee Han M, Quiroga DG, James Almeida K, Haddad Santos D, Perry G, Høilund-Carlsen PF, de Souza Franco E, de Sousa Maia MB.

Expert Opin Biol Ther. 2026 Jan-Feb;26(2):177-188. doi: 10.1080/14712598.2026.2631536. Epub 2026 Feb 14.

Tau phosphorylation homeostasis: Mechanisms, targets, and therapeutic implications in Alzheimer's disease

Lu S, Qiu S, Guan Y, Zhang A, Zhao Q.

Ageing Res Rev. 2026 Jun;118:103097. doi: 10.1016/j.arr.2026.103097. Epub 2026 Mar 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias